Evidence map›Paper›PMID 40502795›Full record

ArticleResearch square2025

Foundation model embeddings for quantitative tumor imaging biomarkers.

Hugo Aerts, Suraj Pai, Ibrahim Hadzic, Andrey Fedorov, Raymond Mak

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hugo AertsMass General Brigham ∣ Harvard Medical School.ORCID 0000-0002-2122-2003
Suraj PaiMass General Brigham ∣ Harvard Medical School.ORCID 0000-0001-8043-2230
Ibrahim HadzicMass General Brigham ∣ Harvard Medical School.
Andrey FedorovBrigham and Women's Hospital.ORCID 0000-0003-4806-9413
Raymond MakMass General Brigham and Harvard Medical School.

Funding

The Boston Lung Cancer Survival CohortU01CA209414 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI David C Christiani · 2017 to 2026
$12.2M
Shared Resource Core 2: Clinical Artificial Intelligence CoreU54CA274516 · NCI · DANA-FARBER CANCER INST · PI Ross I. Berbeco · 2023 to 2026
$8.1M
Quantitative Radiomics System Decoding the Tumor PhenotypeU24CA194354 · NCI · DANA-FARBER CANCER INST · PI AERTS, HUGO, QUACKENBUSH, JOHN · 2015 to 2019
$3.5M
Genotype and Imaging Phenotype Biomarkers in Lung CancerU01CA190234 · NCI · DANA-FARBER CANCER INST · PI AERTS, HUGO, QUACKENBUSH, JOHN · 2015 to 2019
$3.3M
NCI NIH HHS U01 CA190234NCI NIH HHS U01 CA209414NCI NIH HHS U24 CA194354NCI NIH HHS U54 CA274516
6 · The paper itself

Abstract

Foundation models are increasingly used in medical imaging, yet their ability to extract reliable quantitative radiographic phenotypes of cancer across diverse clinical contexts lacks systematic evaluation. Here, we introduce TumorImagingBench, a curated benchmark comprising six public datasets (3,244 scans) with varied oncological endpoints. We evaluate ten medical imaging foundation models, representing diverse architectures and pre-training strategies developed between 2020 and 2025, assessing their performance in deriving deep learning-based radiographic phenotypes. Our analysis extends beyond endpoint prediction performance and compares robustness to common sources of variability and saliency-based interpretability. We additionally compare the mutual similarity of learned embedding representations across each of the models. This comparative benchmarking reveals performance disparities among models and provides critical insights to guide the selection of optimal foundation models for specific quantitative imaging tasks. We publicly release all code, curated datasets, and benchmark results to foster reproducible research and future developments in quantitative cancer imaging.

Identifiers

PMID40502795
PMCPMC12154149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.